Stockreport

Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]

Adagene Inc. - ADS, each representing 1.25 ordinary shares  (ADAG) 
PDF Median overall survival (OS) for the 10 mg/kg cohorts was 19.4 months, with a median follow-up of 17.8 months 4% overall discontinuation rate, no dose limiting toxici [Read more]